PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
1-Year Est. Return 13.3%
This Quarter Est. Return
1 Year Est. Return
+13.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.87B
AUM Growth
+$16.6M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

1
+$76.8M
2
+$65.1M
3
+$59.7M
4
RVMD icon
Revolution Medicines
RVMD
+$54.2M
5
MLTX icon
MoonLake Immunotherapeutics
MLTX
+$45.5M

Top Sells

1
+$84.6M
2
+$57.6M
3
+$38.9M
4
CGEM icon
Cullinan Oncology
CGEM
+$38.9M
5
MRUS icon
Merus
MRUS
+$32.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$420M 14.61%
5,363,379
+363,379
2
$335M 11.66%
4,371,601
+371,601
3
$296M 10.3%
481,305
+931
4
$287M 9.97%
6,553,111
+1,239,022
5
$188M 6.55%
3,515,986
+1,115,412
6
$140M 4.88%
2,531,896
+91,451
7
$120M 4.17%
4,493,929
+1,704,757
8
$116M 4.05%
1,422,787
+795,055
9
$114M 3.96%
616,024
+415,688
10
$97.7M 3.4%
1,910,761
-605,925
11
$96M 3.34%
1,772,211
+840,731
12
$95M 3.3%
1,497,720
13
$71.1M 2.47%
1,689,922
-764,995
14
$60.8M 2.11%
1,437,339
+340,488
15
$58.2M 2.02%
1,283,766
+581,949
16
$42.6M 1.48%
7,304,970
+1,801,370
17
$42.1M 1.47%
3,197,050
+92,564
18
$38.5M 1.34%
5,414,409
+1,509,547
19
$38.4M 1.33%
4,917,412
+307,650
20
$35.6M 1.24%
1,527,205
+259,624
21
$34.9M 1.21%
1,820,079
-1,075,610
22
$33.2M 1.15%
4,236,346
+150,000
23
$27M 0.94%
10,752,354
+84,213
24
$22.4M 0.78%
+485,105
25
$22.2M 0.77%
+770,455
1
2